ginkgolide b has been researched along with Parkinson Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, F; Fang, X; Jiang, Y; Wu, T; Xu, J; Zhao, L | 1 |
| Chen, T; Chen, X; Liu, P; Liu, W; Liu, Y; Shi, X; Tan, H; Wang, Q; Xiong, S; Zhao, Y | 1 |
2 other study(ies) available for ginkgolide b and Parkinson Disease
| Article | Year |
|---|---|
Synergistic Effects of Ginkgolide B and Protocatechuic Acid on the Treatment of Parkinson's Disease.
Topics: Animals; Apoptosis; Biomarkers; Cell Survival; Disease Models, Animal; Drug Synergism; Gene Expression; Ginkgolides; Hydroxybenzoates; Lactones; Mice; Mitochondria; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; PC12 Cells; Rats; Signal Transduction | 2020 |
Polymeric Nanoparticles-Based Brain Delivery with Improved Therapeutic Efficacy of Ginkgolide B in Parkinson's Disease.
Topics: Administration, Oral; Animals; Biological Availability; Blood-Brain Barrier; Brain; Dogs; Embryo, Nonmammalian; Ethylene Glycols; Female; Ginkgolides; Humans; Lactones; Madin Darby Canine Kidney Cells; Male; Mice, Inbred C57BL; Nanoparticles; Neuroprotective Agents; Parkinson Disease; Polyesters; Rats, Sprague-Dawley; Zebrafish | 2020 |